This year we’re leaving screens completely behind and meeting in person because Perspectives in Rheumatic Diseases (PRD) is more than a conference–we’re a community. For us, joining together again is an opportunity to enhance the learning experience. As always, our renowned faculty will bring you the latest advancements in rheumatic diseases, from rheumatoid arthritis, lupus, and vasculitis to…
Register Now Saturday, June 1st, 2024 6:30 – 8:00 PM ET The Westin Boston Seaport District 425 Summer Street Boston, Massachusetts 02210 Hybrid Patients with…
The treatment landscape for ulcerative colitis (UC) is rapidly evolving. Novel pharmacologic agents with different and unique mechanisms of action are significantly advancing the management…
How much do you know about gastroesophageal reflux disease (GERD) and its diagnosis and treatment? In this engaging, interactive symposium, participants will get to test…
Join our expert faculty to delve into the management of common skin conditions in skin of color including atopic dermatitis and hyperpigmentation. They’ll explore the…
Real-time continuous glucose monitoring (rtCGM) facilitates the recognition of patient-specific trends of h yper- and hypoglycemia, allowing for individualized management and behavior modification. Data continue…
We are inviting rheumatology residents and fellows from US programs to participate and attend the Perspectives in Rheumatic Diseases Conference, September 26-28, 2024, at the…
This 90-minute symposium will feature a panel of oncology nursing experts who will review the intricacies of the multiple myeloma (MM) continuum of care. They…
This live panel discussion at ONS Congress 2024 will be focused on real world best practices around the use of bispecific antibodies for the treatment…
The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly. Novel pharmacologic agents with different mechanisms of action are advancing the management of both…
The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly. Novel pharmacologic agents with different mechanisms of action are advancing the management of both…
